Skip to search.
 BSE Down 0.51% NSE Down 0.52%

Taro Pharmaceutical Industries Ltd. (TARO)

-NYSE
132.21 Down 4.27(3.13%) 10:52pm - Nasdaq Real Time Price
Prev Close:136.48
Open:136.33
Bid:132.12 x 100
Ask:132.48 x 200
1y Target Est:205.00
Beta:0.578208
Earnings Date:24 May - 30 May (Est.)
Day's Range:130.22 - 136.73
52wk Range:122.99 - 157.99
Volume:329,904
Avg Vol (3m):121,448
Market Cap:5.66B
P/E (ttm):9.79
EPS (ttm):13.50
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for TARO at this time.

Comparison

Symbol% ChgMkt Cap
TARODown 3.13%5.66B
PRGODown 1.35%13.65B

Key Statistics

Forward P/E (1 yr):9.62
P/S (ttm):6.29
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Mar-16) :11.92
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):0.75

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, engages in the development, manufacture, and marketing of pharmaceutical products in the United States, Canada, Israel, and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback